Spiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines

Infection and Immunity

Volumn 65, Issue 10, 1997, Pages 4322-4329

  Brenner, Catherine ^a,c   Wróblewski, Henri ^b   Le Henaff, Michel ^b   Montagnier, Luc ^a   Blanchard, Alain ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 6; PROTEINASE K; SPIRALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE TRANSFORMATION; MOUSE; MYCOPLASMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; T LYMPHOCYTE ACTIVATION;

EID: 0030843508     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.10.4322-4329.1997     Document Type: Article

References (43)

1. Berg, M., S. Offermanns, R. Seifert, and G. Schultz. 1994. Synthetic lipoprotein Pam3CysSer(Lys)4 is an effective activator of human platelets. Am. J. Physiol. 266:C1684-C1691.
2. Bessler, W. G., and G. Jung. 1992. Synthetic lipoproteins as novel adjuvants. Res. Immunol. 143:548-553.
3. Beven, L., M. Le Hénaff, C. Fontenelle, and H. Wróblewski. 1996. Inhibition of spiralin processing by the lipoprotein antibiotic globomycin. Curr. Microbiol. 33:317-322.
4. Brenner, C., H. Duclohier, V. Krchnak, and H. Wróblewski. 1995. Conformation, pore-forming activity and antigenicity of synthetic peptide analogs of a spiralin putative amphipathic α-helix. Biochim. Biophys. Acta 1235:161-169.
5. Brenner, C., O. Neyrolles, and A. Blanchard. 1996. Mycoplasmas and HIV infection: from epidemiology to their interaction with immune cells. Front. Biosci. 1:42-54.
6. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. 1996. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64:5326-5331.
7. Chevalier, C., C. Saillard, and J. M. Bove. 1991. Spiralins of Spiroplasma citri and Spiroplasma melliferum: amino acid sequences and putative organization in the cell membrane. J. Bacteriol. 172:6090-6097.
8. Cole, B. C., and C. L. Atkin. 1991. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol. Today 12:271-276.
9. Erdile, L. F., M.-A. Brandt, D. J. Warakomski, G. J. Westrack, A. Sadziene, A. G. Barbour, and J. P. Mays. 1993. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61:81-90.
10. Faulkner, C. B., J. W. Simecka, M. K. Davidson, J. K. Davis, T. R. Schoeb, J. R. Lindsey, and M. P. Everson. 1995. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect. Immun. 63:4084-4090.
11. Feng, S.-H., and S.-C. Lo. 1994. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect. Immun. 62:3916-3921.
12. Ferris, S., H. Watson, O. Neyrolles, L. Montagnier, and A. Blanchard. 1995. Characterization of a major Mycoplasma penetrans lipoprotein and of its gene. FEMS Microbiol. Lett. 130:313-320.
13. Foissac, X., C. Saillard, J. Gandar, L. Zreik, and J. M. Bové. 1996. Spiralin polymorphism in strains of Spiroplasma citri is not due to differences in posttranslational palmitoylation. J. Bacteriol. 178:2934-2940.
14. Herbelin, A., E. Ruuth, D. Delorme, C. Michel-Herbelin, and F. Praz. 1994. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect. Immun. 62:4690-4694.
15. Jan, G., M. Fontenelle, M. Le Hénaff, and H. Wróblewski. 1995. Acylation and immunological properties of Mycoplasma gallisepticum membrane proteins. Res. Microbiol. 146:739-750.
16. Krammer, M., R. Wallich, and M. Simon. 1996. The outer surface protein A (OSPA) of Borrelia burgdorferi - a vaccine candidate and bioactive mediator. Infection 24:190-194.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
18. Lecoeur, H., and M. L. Gougeon. 1996. Comparative analysis of flow cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes. J. Immunol. Methods 198:87-99.
19. Le Hénaff, M., C. Brenner, C. Fontenelle, C. Delamarche, and H. Wróblewski. 1991. Does spiralin possess a cleavable N-terminal signal sequence? C. R. Acad. Sci. Paris Ser. III 312(5):189-195.
20. Lo, S.-C. 1992. Mycoplasmas and AIDS, p. 525-545. In J. Maniloff, R. N. McElhaney, L. R.-L. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. ASM Press, Washington, D.C.
21. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843-3853.
22. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J. Exp. Med. 142: 473-482.
23. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
24. Morioka, H., M. Tachibana, M. Machino, and A. Suganuma. 1987. Polymyxin B binding sites in E. coli as revealed by polymyxin B-gold labeling. J. Histochem. Cytochem. 35:229-231.
25. Mühlradt, P. F., M. Kiess, H. Meyer, R. Süssmuth, and R. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951-1958.
26. Neyrolles, O., et al. Unpublished data.
27. Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Curetty, D. A. Harrich, and J. D. Radolf. 1996. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-κB. Infect. Immun. 64:3845-3852.
28. Pietsch, K., S. Ehlers, and E. Jacobs. 1994. Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with Mycoplasma pneumoniae. Microbiology 140:2043-2048.
29. Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866-2877.
30. Rawadi, G., and S. Roman-Roman. 1996. Mycoplasma membrane lipoproteins induce proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun. 64:637-643.
31. Rawadi, G., S. Roman-Roman, M. Castedo, V. Dutilleul, S. Susin, M. Geuskens, and G. Kroemer. 1996. Effects of Mycoplasma fermentans on the myelomonocytic lineage. J. Immunol. 156:670-678.
32. Ruuth, E., and F. Praz. 1989. Interactions between mycoplasmas and the immune system. Immunol. Rev. 112:133-160.
33. Sadziene, A., and A. Barbour. 1996. Experimental immunization against Lyme borreliosis with recombinant OSP proteins - an overview. Infection 24:195-202.
34. Sasaki, Y., A. Blanchard, H. L. Watson, S. Garcia, A. Dulioust, L. Montagnier, and M.-L. Gougeon. 1995. In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals. Infect. Immun. 63:4277-4283.
35. Shimizu. T., Y. Iwamoto, Y. Yanagihara, M. Kurimura, and K. Achiwa. 1994. Mitogenic activity and the induction of tumor necrosis factor by lipopeptide analogs of the N-terminal part of lipoprotein in the outer membrane of E. coli. Biol. Pharm. Bull. 17:980-982.
36. Snapper, C. M., H. Yamaguchi, M. A. Moorman, R. Sneed, D. Smoot, and J. J. Mond. 1993. Natural killer cells induce activated murine B cells to secrete Ig. J. Immunol. 151:5251-5260.
37. Stuart, P. M., R. M. Egan, and J. G. Woodward. 1993. Characterization of MHC induction by Mycoplasma fermentans (incognitus strain). Cell. Immunol. 152:261-270.
38. Watson, H. L., X. Zheng, and G. H. Cassell. 1993. Structural variations and phenotypic switching of mycoplasmal antigens. Clin. Infect. Dis. 17:S183-S186.
39. Wieslander, A., M. J. Boyer, and H. Wróblewski. 1992. Membrane protein structure, p. 93-112. In J. Maniloff, R. N. McElhaney, L. R.-L. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. ASM Press, Washington, D.C.
40. Wise, K. S. 1993. Adaptative surface variation. Trends Microbiol. 1:59-63.
41. Wróblewski, H., K.-E. Johansson, and S. Hjerten. 1977. Purification and characterization of spiralin, the main protein of Spiroplasma citri membrane. Biochim. Biophys. Acta 465:275-289.
42. Wróblewski, H., S. Nyström, A. Blanchard, and A. Wieslander. 1989. Topology and acylation of spiralin. J. Bacteriol. 171:5039-5047.
43. Zhong, W., K.-H. Wiesmuller, M. Kramer, R. Wallich, and M. Simon. 1996. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur. J. Immunol. 26:2749-2750.